Pasithea Therapeutics Corp. (KTTAW) Accumulated Depreciation (2022 - 2025)

Pasithea Therapeutics has disclosed Accumulated Depreciation across 4 years of filings, most recently posting $47939.0 for Q2 2025.

• In Q2 2025, Accumulated Depreciation rose 45.62% year-over-year to $47939.0; the TTM figure through Jun 2025 stood at $47939.0 (up 45.62% YoY), while the FY2024 annual figure was $42353.0, up 80.32% from the prior year.
• Accumulated Depreciation came in at $47939.0 for Q2 2025 at Pasithea Therapeutics, up from $43981.0 in the prior quarter.
• In the past five years, Accumulated Depreciation ranged from a high of $47939.0 in Q2 2025 to a low of $3559.0 in Q4 2022.
• Average Accumulated Depreciation over 4 years is $32510.1, with a median of $35278.0 recorded in 2024.
• Year-over-year, Accumulated Depreciation jumped 559.96% in 2023 and surged 45.62% in 2025.
• Over 4 years, Accumulated Depreciation stood at $3559.0 in 2022, then jumped by 559.96% to $23488.0 in 2023, then surged by 80.32% to $42353.0 in 2024, then advanced by 13.19% to $47939.0 in 2025.
• Per Business Quant data, the three most recent Accumulated Depreciation figures were $47939.0 in Q2 2025, $43981.0 in Q1 2025, and $42353.0 in Q4 2024.